Renaissance Technologies (RenTech)'s LLY Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 165,847 shares of Eli Lilly and Company (LLY) worth $178.23 M, representing 0.28% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in LLY, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2017, adding 2.71 M shares. Largest reduction occurred in Q3 2013, reducing 4.04 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Eli Lilly and Company (LLY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eli Lilly and Company (LLY) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +165,847 | New Buy | 165,847 | $1074.68 |
| Q3 2025 | -261 | Sold Out | 0 | $0.00 |
| Q2 2025 | -96,051 | Reduce 99.73% | 261 | $784.15 |
| Q1 2025 | +42,192 | Add 77.96% | 96,312 | $825.92 |
| Q4 2024 | -203,693 | Reduce 79.01% | 54,120 | $772.02 |
| Q3 2024 | +257,813 | New Buy | 257,813 | $885.94 |
| Q2 2024 | -130,178 | Sold Out | 0 | $0.00 |
| Q1 2024 | -143,685 | Reduce 52.47% | 130,178 | $777.97 |
| Q4 2023 | +138,399 | Add 102.17% | 273,863 | $582.92 |
| Q3 2023 | +122,455 | Add 941.31% | 135,464 | $537.13 |
| Q2 2023 | -440,571 | Reduce 97.13% | 13,009 | $0.47 |
| Q1 2023 | -319,774 | Reduce 41.35% | 453,580 | $0.34 |
| Q4 2022 | -241,293 | Reduce 23.78% | 773,354 | $0.37 |
| Q3 2022 | +613,764 | Add 153.10% | 1.01 M | $323.35 |
| Q2 2022 | +297,183 | Add 286.58% | 400,883 | $324.23 |
| Q1 2022 | -90,247 | Reduce 46.53% | 103,700 | $286.37 |
| Q4 2021 | -859,500 | Reduce 81.59% | 193,947 | $276.22 |
| Q3 2021 | +967,347 | Add 1123.52% | 1.05 M | $231.05 |
| Q2 2021 | -146,847 | Reduce 63.04% | 86,100 | $229.52 |
| Q1 2021 | +232,947 | New Buy | 232,947 | $186.82 |
| Q4 2020 | -481,547 | Sold Out | 0 | $0.00 |
| Q3 2020 | -132,400 | Reduce 21.57% | 481,547 | $148.02 |
| Q2 2020 | +399,347 | Add 186.09% | 613,947 | $164.18 |
| Q1 2020 | +214,600 | New Buy | 214,600 | $138.72 |
| Q4 2019 | -162,699 | Sold Out | 0 | $0.00 |
| Q3 2019 | -2.15 M | Reduce 92.95% | 162,699 | $111.83 |
| Q2 2019 | +1.58 M | Add 218.58% | 2.31 M | $110.79 |
| Q1 2019 | +713,854 | Add 6609.76% | 724,654 | $129.76 |
| Q4 2018 | +10,800 | New Buy | 10,800 | $115.74 |
| Q3 2018 | -488,000 | Sold Out | 0 | $0.00 |
| Q2 2018 | -3.27 M | Reduce 87.01% | 488,000 | $85.33 |
| Q1 2018 | -516,400 | Reduce 12.09% | 3.76 M | $77.37 |
| Q4 2017 | +222,900 | Add 5.50% | 4.27 M | $84.46 |
| Q3 2017 | -1.65 M | Reduce 28.90% | 4.05 M | $85.54 |
| Q2 2017 | +2.71 M | Add 91.08% | 5.69 M | $82.30 |
| Q1 2017 | +1.44 M | Add 93.63% | 2.98 M | $84.11 |
| Q4 2016 | +617,000 | Add 66.91% | 1.54 M | $73.55 |
| Q3 2016 | -1.27 M | Reduce 57.91% | 922,200 | $80.26 |
| Q2 2016 | -22,400 | Reduce 1.01% | 2.19 M | $78.75 |
| Q1 2016 | +1.88 M | Add 565.14% | 2.21 M | $72.01 |
| Q4 2015 | +111,800 | Add 50.59% | 332,805 | $84.26 |
| Q3 2015 | +221,005 | New Buy | 221,005 | $83.69 |
| Q2 2015 | -418,805 | Sold Out | 0 | $0.00 |
| Q1 2015 | -404,395 | Reduce 49.12% | 418,805 | $72.65 |
| Q4 2014 | -940,700 | Reduce 53.33% | 823,200 | $68.99 |
| Q3 2014 | -1.58 M | Reduce 47.22% | 1.76 M | $64.85 |
| Q2 2014 | -1.91 M | Reduce 36.42% | 3.34 M | $62.17 |
| Q1 2014 | -1.81 M | Reduce 25.57% | 5.26 M | $58.86 |
| Q4 2013 | -1.23 M | Reduce 14.79% | 7.06 M | $51.00 |
| Q3 2013 | -4.04 M | Reduce 32.76% | 8.29 M | $50.33 |
| Q2 2013 | +12.33 M | Add 0.00% | 12.33 M | $49.12 |
Renaissance Technologies (RenTech)'s Eli Lilly and Company Investment FAQs
Renaissance Technologies (RenTech) first purchased Eli Lilly and Company (LLY) in Q2 2013, acquiring 12,326,205 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Eli Lilly and Company (LLY) for 51 quarters since Q2 2013.
Renaissance Technologies (RenTech)'s largest addition to Eli Lilly and Company (LLY) was in Q2 2013, adding 12,326,205 shares worth $605.46 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 165,847 shares of Eli Lilly and Company (LLY), valued at approximately $178.23 M.
As of the Q4 2025 filing, Eli Lilly and Company (LLY) represents approximately 0.28% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Eli Lilly and Company (LLY) was 12,326,205 shares, as reported at the end of Q2 2013.